The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.20
Bid: 66.60
Ask: 67.20
Change: -0.20 (-0.30%)
Spread: 0.60 (0.901%)
Open: 67.20
High: 67.20
Low: 67.20
Prev. Close: 67.40
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding - amendment

26 Jan 2024 16:15

RNS Number : 1093B
Coca-Cola Europacific Partners plc
26 January 2024
 

COCA-COLA EUROPACIFIC PARTNERS PLC

(the "Company")

 

Amendment to the announcement made at 10:30 (RNS number: 91928A) on 25 January 2024.

 

The original announcement incorrectly overstated the number of Ordinary Shares sold by certain PDMR/PCAs identified in the announcement to fund the tax liability due in respect of the share issuance on 22 January 2024 pursuant to the Employee Share Purchase Plan (ESPP). This was due to an error made by the share plan administrator. The amended transactions are set out below. All other information was correct.

 

Amendment to notification of transactions of Persons Discharging Managerial Responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

1.

Details of PDMR / PCA

a)

Name

Ana Callol

2.

Reason for notification

a)

Position / status

Chief Public Affairs, Communications and Sustainability Officer

b)

Initial notification / amendment

Amendment

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Coca-Cola Europacific Partners plc

b)

LEI

549300LTH67W4GWMRF57

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument, Identification code

Ordinary Shares of ?0.01 each in the Company ("Ordinary Shares")GB00BDCPN049

b)

Nature of the transaction

Sale of 2.590714 Ordinary Shares on a non-discretionary basis to fund the tax liability due in respect of the issuance of the 5.700147 Ordinary Shares on 22 January 2024 pursuant to the ESPP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

USD $67.575977

2.590714

d)

Aggregated information

- Aggregated volume

- Weighted average price

- Price

 

 

Aggregated Volume: 2.590714 Ordinary Shares

 

Weighted Average Price: USD $67.575977

 

Aggregated Price: USD $175.070030

e)

Date of the transaction

2024-01-22

f)

Place of the transaction

The Nasdaq Stock Market LLC (XNAS)

 

 

 

 

 

 

 

 

 

1.

Details of PDMR / PCA

a)

Name

Jose Antonio Echeverria

2.

Reason for notification

a)

Position / status

Chief Customer Service and Supply Chain Officer

b)

Initial notification / amendment

Amendment

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Coca-Cola Europacific Partners plc

b)

LEI

549300LTH67W4GWMRF57

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument, Identification code

Ordinary Shares of ?0.01 each in the Company ("Ordinary Shares")GB00BDCPN049

b)

Nature of the transaction

Sale of 4.018736 Ordinary Shares on a non-discretionary basis to fund the tax liability due in respect of the issuance of the 8.550488 Ordinary Shares on 22 January 2024 pursuant to the ESPP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

USD $67.575877

4.018736

d)

Aggregated information

- Aggregated volume

- Weighted average price

- Price

 

 

Aggregated Volume: 4.018736 Ordinary Shares

 

Weighted Average Price: USD $67.575877

 

Aggregated Price: USD $271.570012

e)

Date of the transaction

2024-01-22

f)

Place of the transaction

The Nasdaq Stock Market LLC (XNAS)

 

 

 

1.

Details of PDMR / PCA

a)

Name

Victor Rufart

2.

Reason for notification

a)

Position / status

Chief Integration Officer

b)

Initial notification / amendment

Amendment

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Coca-Cola Europacific Partners plc

b)

LEI

549300LTH67W4GWMRF57

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument, Identification code

Ordinary Shares each of ?0.01 in the Company ("Ordinary Shares")GB00BDCPN049

b)

Nature of the transaction

Sale of 3.885405 Ordinary Shares on a non-discretionary basis to fund the tax liability due in respect of the issuance of the 8.550488 Ordinary Shares on 22 January 2024 pursuant to the ESPP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

USD $67.575977

3.885405

d)

Aggregated information

- Aggregated volume

- Weighted average price

- Price

 

 

Aggregated Volume: 3.885405 Ordinary Shares

 

Weighted Average Price: USD $67.575977

 

Aggregated Price: USD $262.560039

e)

Date of the transaction

2024-01-22

f)

Place of the transaction

The Nasdaq Stock Market LLC (XNAS)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLELIIRFIS
Date   Source Headline
25th Apr 20247:00 amRNSQ1 Trading Update & Interim Dividend Declaration
24th Apr 20241:30 pmRNSDirector/PDMR Shareholding
17th Apr 20241:45 pmRNSDirector/PDMR Shareholding
10th Apr 20249:15 amRNSNotice of AGM
2nd Apr 20242:30 pmRNSTotal Voting Rights
21st Mar 20242:00 pmRNSDirector/PDMR Shareholding
20th Mar 20243:00 pmRNSDirector/PDMR Shareholding
18th Mar 20244:30 pmRNSBlock listing Interim Review
15th Mar 202411:59 amRNSAnnual Financial Report
1st Mar 20242:00 pmRNSTotal Voting Rights
23rd Feb 20247:00 amRNSCompletion of joint acquisition of CCBPI
23rd Feb 20247:00 amRNSPreliminary Unaudited Results Q4 & FY 2023
21st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20242:30 pmRNSTotal Voting Rights
30th Jan 202411:30 amRNSPCC approval received to jointly acquire CCBPI
26th Jan 20244:15 pmRNSDirector/PDMR Shareholding - amendment
25th Jan 202410:30 amRNSDirector/PDMR Shareholding
22nd Jan 20243:15 pmRNSDirector/PDMR Shareholding
17th Jan 202411:30 amRNSDirector/PDMR Shareholding
2nd Jan 20241:30 pmRNSTotal Voting Rights
20th Dec 202311:15 amRNSDirector/PDMR Shareholding
18th Dec 202312:15 pmRNSDirector/PDMR Shareholding
15th Dec 20233:40 pmRNSDirector/PDMR Shareholding
14th Dec 202311:00 amRNSDirectorate Change
1st Dec 20231:45 pmRNSTotal Voting Rights
28th Nov 20234:00 pmRNSDirector/PDMR Shareholding
24th Nov 20232:30 pmRNSUpdate statement on 2023 AGM voting results
21st Nov 20234:30 pmRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSUpdate re acquisition of CCBPI
1st Nov 20231:45 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSQ3 Trading Update & Interim Dividend Declaration
25th Oct 20231:30 pmRNSDirector/PDMR Shareholding
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
13th Oct 20232:30 pmRNSDirector/PDMR Shareholding
20th Sep 20234:45 pmRNSDirector/PDMR Shareholding
18th Sep 20234:50 pmRNSBlock listing Interim Review
1st Sep 20231:30 pmRNSTotal Voting Rights
22nd Aug 20233:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:01 amRNSResults for the six months ended 30 June 2023
2nd Aug 20237:00 amRNSProposed joint acquisition of CCBPI
1st Aug 20231:05 pmRNSTotal Voting Rights
25th Jul 20234:00 pmRNSDirector/PDMR Shareholding
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.